Vimarsana.com

Latest Breaking News On - Hedge funds weigh in on processa pharmaceuticals - Page 1 : comparemela.com

Equities Analysts Set Expectations for Processa Pharmaceuticals, Inc.'s Q1 2025 Earnings (NASDAQ:PCSA)

Equities Analysts Set Expectations for Processa Pharmaceuticals, Inc.'s Q1 2025 Earnings (NASDAQ:PCSA)
dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.

Processa-pharmaceuticals-stock-performance
Processa-pharmaceuticals-company-profile
Nasdaq
Hedge-funds-weigh-in-on-processa-pharmaceuticals
Processa-pharmaceuticals
Securities-exchange-commission
News-ratings-for-processa-pharmaceuticals-daily
Processa-pharmaceuticals-inc
Free-report
Processa-pharmaceutical
Get-free-report

Processa Pharmaceuticals, Inc. (NASDAQ:PCSA) CEO George K. Ng Acquires 10,000 Shares of Stock

Processa Pharmaceuticals, Inc. (NASDAQ:PCSA – Get Free Report) CEO George K. Ng purchased 10,000 shares of Processa Pharmaceuticals stock in a transaction that occurred on Tuesday, January 30th. The stock was acquired at an average price of $2.70 per share, with a total value of $27,000.00. Following the transaction, the chief executive officer now owns […]

Walleye-capital
Securities-exchange-commission
Processa-pharmaceuticals-inc
Maxim-group
Processa-pharmaceuticals-trading-down
Renaissance-technologies
News-ratings-for-processa-pharmaceuticals-daily
Processa-pharmaceuticals-company-profile
Nasdaq
Processa-pharmaceuticals
Raymond-james-financial-services-advisors-inc

Processa Pharmaceuticals (NASDAQ:PCSA) Shares Scheduled to Reverse Split on Monday, January 22nd

Shares of Processa Pharmaceuticals, Inc. (NASDAQ:PCSA – Free Report) are set to reverse split before the market opens on Monday, January 22nd. The 1-20 reverse split was announced on Monday, January 22nd. The number of shares owned by shareholders will be adjusted after the closing bell on Monday, January 22nd. Processa Pharmaceuticals Stock Performance NASDAQ […]

Raymond-james-financial-services-advisors-inc
Renaissance-technologies
Dimensional-fund-advisors
Nasdaq
Processa-pharmaceuticals-stock-performance
Hedge-funds-weigh-in-on-processa-pharmaceuticals
Sigma-securities
News-ratings-for-processa-pharmaceuticals-daily
Processa-pharmaceuticals
Processa-pharmaceuticals-inc
Maxim-group

Processa Pharmaceuticals (NASDAQ:PCSA) Shares Up 2.6%

Processa Pharmaceuticals, Inc. (NASDAQ:PCSA – Get Rating) shares shot up 2.6% during mid-day trading on Tuesday . The company traded as high as $0.57 and last traded at $0.56. 35,908 shares changed hands during mid-day trading, a decline of 82% from the average session volume of 201,922 shares. The stock had previously closed at $0.55. […]

Patrick-lin
David-young
Raymond-james-financial-services-advisors-inc
News-ratings-for-processa-pharmaceuticals-daily
Dimensional-fund-advisors
Processa-pharmaceuticals
Sigma-securities
Nasdaq
Hedge-funds-weigh-in-on-processa-pharmaceuticals
Renaissance-technologies
Processa-pharmaceuticals-trading-down
Processa-pharmaceuticals-company-profile

UBS AG FI Enhanced Global High Yield ETN (NYSEARCA:FIHD) Stock Price Down 1.5%

Processa Pharmaceuticals, Inc. (NASDAQ:PCSA – Get Rating) shares shot up 2.6% during mid-day trading on Tuesday . The company traded as high as $0.57 and last traded at $0.56. 35,908 shares changed hands during mid-day trading, a decline of 82% from the average session volume of 201,922 shares. The stock had previously closed at $0.55. […]

David-young
Patrick-lin
News-ratings-for-processa-pharmaceuticals-daily
Nasdaq
Raymond-james-financial-services-advisors-inc
Processa-pharmaceuticals-company-profile
Processa-pharmaceuticals
Dimensional-fund-advisors
Renaissance-technologies
Processa-pharmaceuticals-trading-down
Hedge-funds-weigh-in-on-processa-pharmaceuticals
Sigma-securities

vimarsana © 2020. All Rights Reserved.